All stock lists
Unlock the score
ProMIS Neurosciences Inc. (NASDAQ:PMN)
CA · Delayed Price · Currency is USD
Healthcare · Biotechnology
8.06-0.28 (-3.36%)
Market cap
$72.3M
Insider Score
Health Score
Analyst consensus
Listed since
Jan 10, 2007
Website
Insider Score
/ 100
PMN Insider Score
ProMIS Neurosciences Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
PMN Stock Insider Trading Activity
PMN stock’s insider trading shows 1 purchase for an estimated $30.32K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days1 qualifying buy1 insider$30.32K bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Kaplan Johanne Other | Buy | 2,280 | $13.30 | $30.32K | 57.9% | 6,221 | Aug 5, 2026 | BExec Buy | Form 4 |
| Kirwin Patrick D. Director | Buy | 4,000 | $11.33 | $45.32K | 613% | 4,653 | Apr 22, 2026 | AFirst BuyStake Doubler | Form 4 |
| Williams Eugene Director | Buy | 2,000 | $24.40 | $48.80K | 19.2% | 12,397 | Mar 5, 2026 | C | Form 4 |
| Williams Eugene Director | Buy | 2,000 | $24.00 | $48.00K | 23.8% | 10,397 | Mar 4, 2026 | C | Form 4 |
| Williams Eugene Director | Buy | 1,000 | $21.89 | $21.89K | 13.5% | 8,397 | Mar 3, 2026 | C | Form 4 |
| Williams Eugene Director | Buy | 1,000 | $22.53 | $22.53K | 15.6% | 7,397 | Mar 2, 2026 | CFirst Buy | Form 4 |
| Kaplan Johanne Other | Buy | 1,629 | $15.35 | $25.01K | 70.5% | 3,941 | Feb 19, 2026 | BFirst BuyExec Buy | Form 4 |
| Milbury Max A. Other | Award | 6,595 | $12.13 | $80.00K | 364% | 8,409 | Feb 3, 2026 | — | Form 4 |
| Yu Fan Other | Buy | 700,741 | $12.13 | $8.50M | 289% | 943,090 | Feb 3, 2026 | — | Form 4 |
| Kirwin Patrick D. Director | Award | 3,050 | $12.13 | $37.00K | 146% | 5,135 | Feb 3, 2026 | — | Form 4 |
| Warma Neil K CEO | Award | 6,183 | $12.13 | $75.00K | New | 6,183 | Feb 3, 2026 | — | Form 4 |
| Cashman Neil Director | Award | 4,122 | $12.13 | $50.00K | New | 4,122 | Feb 3, 2026 | — | Form 4 |
| Kaplan Johanne Other | Award | 2,060 | $12.13 | $24.99K | 817% | 2,312 | Feb 3, 2026 | — | Form 4 |
| Milbury Max A. Other | Buy | 30,392 | $0.49 | $14.89K | 203% | 45,389 | Oct 3, 2025 | — | Form 4 |
| Jeremy M. Sclar 2012 Irrevocable Family Trust Other | Option exercise | 697,674 | — | — | 23.2% | 3,710,459 | Jul 25, 2025 | — | Form 4 |
| Jeremy M. Sclar 2012 Irrevocable Family Trust Other | Option exercise | 697,674 | — | — | 43.1% | 2,315,111 | Jul 25, 2025 | — | Form 4 |
| Jeremy M. Sclar 2012 Irrevocable Family Trust Other | Option exercise | 697,674 | — | — | 30.1% | 3,012,785 | Jul 25, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Award (A) — Grant or award from the company, not a purchase
- Option exercise (X) — Exercise of an in- or at-the-money derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.